{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:03:59Z","timestamp":1792116239769,"version":"4.4.0"},"reference-count":59,"publisher":"JMIR Publications Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Mhealth Uhealth"],"abstract":"\n Background<\/jats:title>\n Digital therapeutic care apps provide a new effective and scalable approach for people with nonspecific low back pain (LBP). Digital therapeutic care apps are also driven by personalized decision-support interventions that support the user in self-managing LBP, and may induce prolonged behavior change to reduce the frequency and intensity of pain episodes. However, these therapeutic apps are associated with high attrition rates, and the initial prescription cost is higher than that of face-to-face physiotherapy. In Germany, digital therapeutic care apps are now being reimbursed by statutory health insurance; however, price targets and cost-driving factors for the formation of the reimbursement rate remain unexplored.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The aim of this study was to evaluate the cost-effectiveness of a digital therapeutic care app compared to treatment as usual (TAU) in Germany. We further aimed to explore under which circumstances the reimbursement rate could be modified to consider value-based pricing.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We developed a state-transition Markov model based on a best-practice analysis of prior LBP-related decision-analytic models, and evaluated the cost utility of a digital therapeutic care app compared to TAU in Germany. Based on a 3-year time horizon, we simulated the incremental cost and quality-adjusted life years (QALYs) for people with nonacute LBP from the societal perspective. In the deterministic sensitivity and scenario analyses, we focused on diverging attrition rates and app cost to assess our model\u2019s robustness and conditions for changing the reimbursement rate. All costs are reported in Euro (\u20ac1=US $1.12).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Our base case results indicated that the digital therapeutic care strategy led to an incremental cost of \u20ac121.59, but also generated 0.0221 additional QALYs compared to the TAU strategy, with an estimated incremental cost-effectiveness ratio (ICER) of \u20ac5486 per QALY. The sensitivity analysis revealed that the reimbursement rate and the capability of digital therapeutic care to prevent reoccurring LBP episodes have a significant impact on the ICER. At the same time, the other parameters remained unaffected and thus supported the robustness of our model. In the scenario analysis, the different model time horizons and attrition rates strongly influenced the economic outcome. Reducing the cost of the app to \u20ac99 per 3 months or decreasing the app\u2019s attrition rate resulted in digital therapeutic care being significantly less costly with more generated QALYs, and is thus considered to be the dominant strategy over TAU.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The current reimbursement rate for a digital therapeutic care app in the statutory health insurance can be considered a cost-effective measure compared to TAU. The app\u2019s attrition rate and effect on the patient\u2019s prolonged behavior change essentially influence the settlement of an appropriate reimbursement rate. Future value-based pricing targets should focus on additional outcome parameters besides pain intensity and functional disability by including attrition rates and the app\u2019s long-term effect on quality of life.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/35042","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T10:31:48Z","timestamp":1644229908000},"page":"e35042","source":"Crossref","is-referenced-by-count":38,"title":["Digital Therapeutic Care Apps With Decision-Support Interventions for People With Low Back Pain in Germany: Cost-Effectiveness Analysis"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3167-8741","authenticated-orcid":false,"given":"Daniel","family":"Lewkowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6476-3451","authenticated-orcid":false,"given":"Attila M","family":"Wohlbrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6868-6676","authenticated-orcid":false,"given":"Erwin","family":"Bottinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60610-7"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204428"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e318133fad8"},{"key":"ref4","unstructured":"Krankheitskosten: Deutschland, Jahre, Krankheitsdiagnosen (ICD-10, M54) im Jahr 2015Statistisches Bundesamt2021-10-01https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Gesundheit\/Krankheitskosten\/_inhalt.html"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2008.04.005"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/brs.0b013e3181cd656f"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-014-1508-1"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00164-6"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-018-5673-2"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0883"},{"key":"ref11","unstructured":"Bundes\u00e4rztekammer (B\u00c4K)Kassen\u00e4rztliche Bundesvereinigung (KBV)Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)National Care Guideline (NVL) Non-specific low back pain, 2nd editionNationale Versorgunges Leitlinen20172022-01-28https:\/\/tinyurl.com\/2p8v2za9"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2196\/26612"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2196\/15617"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.7290"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2196\/10201"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S260761"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1178632920977894"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-019-0109-x"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-018-0076-7"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.11.007"},{"key":"ref21","unstructured":"BehnerPKlinkAVisserSB\u00f6ckenJEtgetonSEffekte einer gesteigerten Therapietreue: Bessere Gesundheit und h\u00f6here Arbeitsproduktivit\u00e4t durch nachhaltige \u00c4nderung des PatientenverhaltensBooz & Company, Bertelsmann Stiftung20122021-10-02https:\/\/www.bertelsmann-stiftung.de\/fileadmin\/files\/BSt\/Presse\/imported\/downloads\/xcms_bst_dms_36214_36215_2.pdf"},{"key":"ref22","unstructured":"Gesundheitsausgaben in Deutschland als Anteil am BIP und in Millionen \u20ac (absolut und je Einwohner - Gliederungsmerkmale: Jahre)Gesundheitsberichterstattung des Bundes2021-10-11https:\/\/www.gbe-bund.de\/gbe\/pkg_isgbe5.prc_menu_olap?p_uid=gastd&p_aid=20703791&p_sprache=D&p_help=0&p_indnr=522&p_indsp=&p_ityp=H&p_fid"},{"key":"ref23","unstructured":"National Health Expenditures 2020 HighlightsUS Centers for Medicare & Medicaid Services2021-12-10https:\/\/www.cms.gov\/files\/document\/highlights.pdf"},{"key":"ref24","unstructured":"The fast-track process for digital health applications according to section 139e SGB V: A guide for manufacturers, service providers and usersFederal Institute for Drugs and Medical Devices (BfArM)2020-11-05https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/EN\/MedicalDevices\/DiGA_Guide.html"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0306-7"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199813040-00003"},{"key":"ref27","unstructured":"Filipovi\u0107-PierucciAZarcaKDurand-ZaleskiIMarkov models for health economic evaluations: the R package heemodarXiv20172021-02-28http:\/\/arxiv.org\/abs\/1702.03252"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.02.002"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/0272989x08315241"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/0272989x9301300409"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-019-00551-x"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(94)00279-N"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003838"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1071-2"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare4030044"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2196\/12505"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2196\/18729"},{"key":"ref38","unstructured":"Einheitlicher Bewertungsma\u00dfstabKassen\u00e4rztliche Bundesvereinigung20052021-06-02https:\/\/www.kbv.de\/html\/ebm.php"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/01.brs.0000190448.69091.53"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9866-y"},{"key":"ref41","unstructured":"BuchholzMThe German version of the Veterans Rand Six Dimension (VR-6D) in the field of quality-of-life research: Translation, evaluation of methodological properties and application-oriented comparison. DissertationUniversitat Greifswald2021-05-02https:\/\/nbn-resolving.org\/urn:nbn:de:gbv:9-opus-38915"},{"key":"ref42","unstructured":"Bundeseinheitliches Positionsnummernverzeichnis f\u00fcr HeilmittelleistungenGKV-Spitzenverband20202021-06-02https:\/\/www.gkv-datenaustausch.de\/media\/dokumente\/leistungserbringer_1\/sonstige_leistungserbringer\/positionsnummernverzeichnisse_archiv\/Heilmittel_20200424.pdf"},{"key":"ref43","unstructured":"DiGa-Verzeichnis: Information f\u00fcr FachkreiseFederal Institute for Drugs and Medical Devices (BfArM)2021-08-12https:\/\/diga.bfarm.de\/de\/verzeichnis\/387\/fachkreise"},{"key":"ref44","unstructured":"H\u00f6he des durchschnittlichen Bruttogehalts im Monat je Arbeitnehmer in Deutschland von 1991 bis 2020Statista2021-05-12https:\/\/de.statista.com\/themen\/293\/durchschnittseinkommen\/#dossier-chapter1"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2013-101571"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S232792"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny062"},{"key":"ref48","unstructured":"Guide to the processes of technology appraisalNational Institute for Health and Clinical Excellence (NICE)2018042021-10-04https:\/\/www.nice.org.uk\/Media\/Default\/About\/what-we-do\/NICE-guidance\/NICE-technology-appraisals\/technology-appraisal-processes-guide-apr-2018.pdf"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-019-00471-w"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2017.09.001"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-10-74"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002057"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000003539"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000003097"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2017.1372252"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2017-098765"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-5013-1"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1177\/2192568218765483"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-016-0268-8"}],"container-title":["JMIR mHealth and uHealth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/mhealth.jmir.org\/2022\/2\/e35042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:55:55Z","timestamp":1782842155000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhealth.jmir.org\/2022\/2\/e35042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2196\/35042","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.35042","asserted-by":"object"}]},"ISSN":["2291-5222"],"issn-type":[{"value":"2291-5222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]}}}